Learning about the effects and pharmacology of cannabis has been a slow but rewarding journey.
I thought I knew so much when I first tried it roughly 10 years ago.
I knew about the difference between sativas and indicas, how most allege to experience stimulating effects from the former and sedating effects from the latter. I knew that there was a fundamental difference between the experience of vaporizing flower versus concentrates, not just for the higher concentration of THC in each hit, but also the complexe array of cannabinoids and terpenes that are present in dried cannabis flower. Sometimes these cannabinoids and terpenes get destroyed during the extraction process, with some extraction methods yielding better results than others. But there was something important about terpenes that took me years to understand. I took it for granted that I experienced something different with a sativa opposed to an indica, but I guess I assumed it had to do with CBD levels. I could not have been more wrong. Myrcene is a common terpene in sedating strains of cannabis. Current pharmacologists believe that higher levels of myrcene in ratio to other terpenes is to blame for one strain seeming more indica-like versus another. The dispensaries are doing their best, but their employees are ignorant to these details. The dispensary technicians often have no clue that sativas were usually plants with longer leaves and indicas had short and stout leaves. Either variety can have high or low levels of myrcene, which makes the traditional sativa-indica distinction fairly problematic. It’s not the size of the leaf that determines the form or type of psychoactivity, nor does the whole psychoactivity tell you what kind of leaf to expect from the strain you’re consuming.